Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About ...
Several clinical trials have demonstrated the relative tolerability of losartan. [8,14,18,19,20] The most frequent adverse reaction, as observed in a clinical trial of 2900 patients assessing the ...
The Food and Drug Administration is again expanding its recall of widely prescribed blood pressure drugs due to contamination with a cancer-linked chemical. Monday's announcement targets an additional ...
The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. Sandoz Inc. is voluntarily recalling losartan potassium ...
COMMACK, NY, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value ...
Aurobindo Pharma USA has recalled 80 lots of medicines containing valsartan because of the presence of the probable carcinogen N-nitrosodiethylamine (NDEA), marking the latest recall of tainted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback